ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer.

Dun-Chang Mo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.